C16 Biosciences

C16 Biosciences is a biotechnology company producing clean and safe alternatives to palm oil.

Funding reportedLast round: Undisclosed round

BiotechnologyNew York, United States

What company datasets say C16 Biosciences raised

Funding, as reported

Reported in all$34Min dollars

Rounds8

Last roundUndisclosed round

Last round dateJan 2024

Investors listed21

SEC Form D$49M sold, 4 filings, last Mar 2023

Y CombinatorS18

From C16 Biosciences's own website and the SEC filings it signed: 2 founders.

Shara TickuCo-Founder & Chief Executive OfficerNamed on its 2023 Form D

David HellerCo-Founder & Chief Operating Officer

On the board, as filediHarold McNamaraPeter Turner

Investors who name them

Each firm lists C16 Biosciences on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

Startups like it

Add your raise, your deck and your story, and put C16 Biosciences in front of investors. Or tell us what we have wrong.